25 results
8-K
EX-3.2
SYRE
Spyre Therapeutics Inc.
18 Mar 24
Spyre Therapeutics Announces $180 Million Private Placement
8:31am
8-K
EX-3.1
SYRE
Spyre Therapeutics Inc.
5 Feb 24
Entry into a Material Definitive Agreement
7:36am
S-1/A
EX-3.2
SYRE
Spyre Therapeutics Inc.
IPO registration (amended)
5 Feb 24
12:00am
S-1
EX-3.1
SYRE
Spyre Therapeutics Inc.
IPO registration
22 Dec 23
4:32pm
S-1
EX-3.3
SYRE
Spyre Therapeutics Inc.
IPO registration
22 Dec 23
4:32pm
8-K
EX-3.1
nb68qbpkg0ny679kis
8 Dec 23
Spyre Therapeutics Announces $180 Million Private Placement
8:45am
8-K
EX-3.1
nbw0dxy5xb6ohf
28 Nov 23
Appoints CEO and Additional Directors, and Expands Leadership Team to
7:33am
8-K
EX-3.1
n5uq r24xf0rt
22 Nov 23
Amendments to Articles of Incorporation or Bylaws
8:45pm
8-K
EX-3.1
8kg17z
8 Sep 23
Material Modifications to Rights of Security Holders
5:05pm
8-K
EX-3.1
cx0cb
23 Jun 23
Entry into a Material Definitive Agreement
9:16am
8-K
EX-3.1
a0avp6tf
19 Dec 22
Amendments to Articles of Incorporation or Bylaws
4:06pm
8-K
EX-3.1
hy8d9lmq
3 Apr 20
Amendments to Articles of Incorporation or Bylaws
4:30pm